Cargando…
COVID-19 vaccines: addressing hesitancy in young people with allergies
Autores principales: | Abrams, Elissa M, Shaker, Marcus, Sinha, Ian, Greenhawt, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372552/ https://www.ncbi.nlm.nih.gov/pubmed/34416192 http://dx.doi.org/10.1016/S2213-2600(21)00370-2 |
Ejemplares similares
-
Primary care provider-reported prevalence of vaccine and polyethylene glycol allergy in Canada
por: Abrams, Elissa M., et al.
Publicado: (2021) -
COVID-19 in Europe: new challenges for addressing vaccine hesitancy
por: Karafillakis, Emilie, et al.
Publicado: (2022) -
Addressing COVID-19 vaccine hesitancy: is official communication the key?
por: Schwarzinger, Michaël, et al.
Publicado: (2021) -
Allergists Can Safely Evaluate and Revaccinate Individuals With Immediate Allergic Reactions to mRNA COVID-19 Vaccines
por: Greenhawt, Matthew, et al.
Publicado: (2021) -
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies
por: Shaker, Marcus, et al.
Publicado: (2021)